Avandia Sales Drop as the Public Turns to Alternatives Such as Actos
Following a recent report in the New England Journal of Medicine that cast doubt on the safety of Avandia, the public has begun to move away from using the drug. This, in turn, has driven interest to other Type 2 diabetes drugs sales such as Actos, which is also used to control blood sugar levels in patients with Type 2 diabetes.
Just as with Avandia, however, the Food and Drug Administration (FDA) has requested that a strict warning be added to Actos about its link to cardiovascular risks.
Actos is an oral medicine for people whith Type 2 diabetes who do not use daily insulin injections. It should not be used for treating Type 1 diabetes.
According to the medication's labeling, before taking Actos, patients should consult their doctor if they have congestive heart failure or heart disease; a history of heart attack or stroke, or liver disease.
In addition, Actos may be harmful to an unborn baby, so it is necessary to discuss with your doctor if you are pregnant or plan to become pregnant during treatment.
An article in the Philadelphia Inquirer mentions the drug Januvia, as a current rival to the "beleaguered Avandia." However, the article goes on to say that there are side effects to Januvia, including ankle swelling. The Inquirer article concludes that patients need to tread carefully when switching to new medications.
If you or a loved one has suffered cardiac complications after ingesting Avandia, you deserve the guidance of an experienced drug attorney. Get a free case review by filling out the form below.
Rosiglitazone Learn About the Diabetes Drug Rosiglitazone, Brand Name Avandia
Rosiglitazone Increases the Risk for Serious Cardiovascular Problems
Diabetes Medication After Avandia Scare, Older Diabetes Drug Deemed Best Choice for Type 2
Experts: Look Beyond Avandia to Treat Type 2 Diabetes With Older Meds
News & Warnings Avandia News and Information | Weitz & Luxenberg
Bloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001